Vector borne and zoonotic diseases
-
Vector Borne Zoonotic Dis. · Mar 2020
ReviewPatterns, Drivers, and Challenges of Vector-Borne Disease Emergence.
Vector-borne diseases are emerging at an increasing rate and comprise a disproportionate share of all emerging infectious diseases. Yet, the key ecological and evolutionary dimensions of vector-borne disease that facilitate their emergence have not been thoroughly explored. This study reviews and synthesizes the existing literature to explore global patterns of emerging vector-borne zoonotic diseases (VBZDs) under changing global conditions. ⋯ The most common potential driver of these emerging zoonoses is land use change, but for many diseases, the driver is unknown, revealing a critical research gap. While most reported VBZDs are emerging in the northern latitudes, after correcting for sampling bias, Africa is clearly a region with the greatest share of emerging VBZD. We highlight critical gaps in our understanding of VBZD emergence and emphasize the importance of interdisciplinary research and consideration of deeper evolutionary processes to improve our capacity for anticipating where and how such diseases have and will continue to emerge.
-
Vector Borne Zoonotic Dis. · Mar 2019
What Have We Learned About Middle East Respiratory Syndrome Coronavirus Emergence in Humans? A Systematic Literature Review.
Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in humans in 2012. A systematic literature review was conducted to synthesize current knowledge and identify critical knowledge gaps. ⋯ There has been substantial MERS-CoV research since 2012, but significant knowledge gaps persist, especially in epidemiology and natural history of the infection. There have been few rigorous studies of baseline prevalence, transmission, and spectrum of disease. Terms such as "camel exposure" and the epidemiological relationships of cases should be clearly defined and standardized. We strongly recommend a shared and accessible registry or database. Coronaviruses will likely continue to emerge, arguing for a unified "One Health" approach.
-
Currently, there are no licensed vaccines or therapies available against chikungunya virus (CHIKV), and these were subjects discussed during a CHIKV meeting recently organized in Langkawi, Malaysia. In this review, we chart the approaches taken in both areas. ⋯ The most promising antivirals so far discovered are reviewed, with a special focus on the virus-encoded replication proteins as potential targets. Within the vaccines in development, our review emphasizes the various strategies in parallel development that are unique in the vaccine field against a single disease.
-
Vector Borne Zoonotic Dis. · Mar 2015
ReviewEmergence of neural angiostrongyliasis in eastern Australia.
Despite an apparent increase in cases of angiostrongyliasis in humans and animals in Australia, the epidemiology of infection with the two species of Angiostrongylus that co-exist in this country, namely A. cantonensis and A. mackerrasae, is poorly understood. This knowledge gap is particularly important with respect to A. mackerrasae, a species evidently native to Australia, as its ability to cause disease in humans is unknown. Likewise, there is little information on the roles of native and introduced species of rodents and molluscs as hosts of Angiostrongylus species in Australia. This review focuses on the gaps in the knowledge about the two species, highlighting the need for epidemiological and pathogenesis studies on the native lungworm A. mackerrasae.
-
Vector Borne Zoonotic Dis. · Dec 2011
ReviewThe status of Rift Valley fever in animals in Saudi Arabia: a mini review.
In August-September 2000, an overwhelming outbreak of Rift Valley fever (RVF) struck the southwestern part of Saudi Arabia and adjoining Yemeni territories. During the outbreak, which was the first ever to be recorded outside Africa, around 40,000 animals, mostly sheep and goats, died or aborted and 883 cases, with 124 deaths, were recorded among humans in Saudi Arabia. An additional 1328 human cases, with 166 deaths, were concurrently recorded in northwestern Yemen. ⋯ However, the virus persisted in a cryptic form in the original area of the epizootic, resulting in intermittent diagnosis of few cases throughout the past 10 years. To date, however, no evidence was found of virus activity outside that area. This review provides, from a veterinary perspective, a brief account of the events surrounding the epizootic and its present status in Saudi Arabia and emphasizes the need for vigilance, preparedness, and regular monitoring of the disease by serosurveillance methods.